Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
252 hedge funds and large institutions have $3.24B invested in Inari Medical, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 97 increasing their positions, 85 reducing their positions, and 34 closing their positions.
15% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 34
14% more repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 85
1% more funds holding
Funds holding: 250 → 252 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $3.3B → $3.24B (-$66.9M)
59% less call options, than puts
Call options by funds: $15.5M | Put options by funds: $38M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$40.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$26M |
| 3 |
SPC
Slate Path Capital
New York
|
+$25.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19.6M |
| 5 |
JP Morgan Chase
New York
|
+$17.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$52.9M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$47.1M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$32.1M |
| 4 |
Millennium Management
New York
|
-$23.1M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
-$15.1M |
NARI Hedge Fund Activity: Q4 2023 in Review
252 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q4 2023, worth a combined $3.24B — down 2% from $3.3B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new NARI positions and 34 closed out — a net gain of 5 holders — while 97 added to existing stakes and 85 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $40.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $52.9M.
- 252 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q4 2023, up from 250 in Q3 2023.
- Funds reported $3.24B of Inari Medical, Inc. Common Stock stock for Q4 2023, down 2% quarter-over-quarter.
- 39 funds opened new Inari Medical, Inc. Common Stock positions in Q4 2023 and 34 closed out, a net change of +5 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q4 2023 was Morgan Stanley, an estimated $40.3M added.
- The largest Inari Medical, Inc. Common Stock seller in Q4 2023 was T. Rowe Price Associates, an estimated $52.9M sold.
Based on aggregated 13F filings for Q4 2023.